JournalQ1· SCImago 2025
Nature Reviews Drug Discovery
ISSN 1474-1776
- Q1Quartile
- 32.00SJR
- 428h-index
- 1papers summarised
About this journal
Nature Reviews Drug Discovery is a Q1 journal by SCImago Journal Rank (2025 data), with an SJR of 32.00 and an h-index of 428. Most of its papers in the Pofolia pool fall under Family Practice. Pofolia holds AI summaries of 1 paper(s) from this journal; the most cited is “Overcoming barriers to patient adherence: the case for developing innovative drug…” (454 citations).
The quartile (Q1–Q4) is the journal's percentile position within its subject area by SCImago Journal Rank; Q1 is the top 25%. What is a Q1 journal?
Papers we summarise from this journal
- Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems2023 · 454 citations
Journals in the same field
| Journal | Quartile | SJR | Summaries |
|---|---|---|---|
| New England Journal of Medicine | Q1 | 18.00 | 3 |
| Circulation | Q1 | 8.00 | 1 |
| European Urology | Q1 | 8.00 | 1 |
| Diabetes Care | Q1 | 7.00 | 1 |
| JAMA | Q1 | 5.00 | 2 |
| European Heart Journal | Q1 | 5.00 | 1 |
| Circulation Research | Q1 | 5.00 | 1 |
| JAMA Internal Medicine | Q1 | 4.00 | 2 |
| Nature Communications | Q1 | 4.00 | 1 |
| Proceedings of the National Academy of Sciences of the United States of America | Q1 | 3.00 | 2 |
See every journal in the field →
Follow these journals on Pofolia
Pick your fields and new papers from their journals land in your feed every day with AI summaries. Free.
Start free